CSF1R and central nervous system cancer: Pyonteck et al. also demonstrated that the use of CSF1R inhibitor, BLZ945, inhibited the progression of intracranial xenografts of conventional human glioma cells via the facilitation of GAM antitumor gene secretion (Figure 5 and Table 1) [190].